Ranbaxy Laboratories Q2 profit after tax at Rs.998.30 million, revenue at Rs.1005.02 Crores

Ranbaxy Laboratories Ltd has announced the following Unaudited Results for the quarter ended June 30, 2006:

The Company has posted a profit after tax of Rs 998.30 million for the quarter ended June 30, 2006 (Q2 FY 06-07) as compared to Rs 764.90 million for the quarter ended June 30, 2005 (Q2 FY 05-06). Total Income (net of excise) has increased from Rs 10050.20 million in Q2 FY 05-06 to Rs 10837.80 million for Q2 FY 06-07.

The Consolidated Results are as follows:

The Group has posted a profit after tax & Minority Interests of Rs 1211 million for the quarter ended June 30, 2006 (Q2 FY 06-07) as compared to Rs 1013 million for the quarter ended June 30, 2005 (Q2 FY 05-06). Total Income (net of excise) has increased from Rs 13704 million in Q2 FY 05-06 to Rs 14713 million for Q2 FY 06-07.

Source : Equity Bulls

Keywords